Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: An individual participant data analysis

61Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

Objective: The objective of the study was to compare the CHD risk of subclinical hypothyroidism with and without thyroid peroxidase antibodies (TPOAbs). Context: Subclinical hypothyroidism has been associated with increased risk of coronary heart disease (CHD), particularly with thyrotropin levels of 10.0 mIU/L or greater. The measurement of thyroid antibodies helps predict the progression to overt hypothyroidism, but it is unclear whether thyroid autoimmunity independently affects CHD risk. Copyright Data Sources and Study Selection: A MEDLINE and EMBASE search from 1950 to 2011 was conducted for prospective cohorts, reporting baseline thyroid function, antibodies, and CHD outcomes. Data Extraction: Individual data of 38 274 participants from six cohorts for CHD mortality followed up for 460 333 person-years and 33 394 participants from four cohorts for CHD events. Data Synthesis: Among 38 274 adults (median age 55 y, 63% women), 1691 (4.4%) had subclinical hypothyroidism, of whom 775 (45.8%) had positive TPOAbs. During follow-up, 1436 participants died of CHD and 3285 had CHD events. Compared with euthyroid individuals, age- and genderadjusted risks of CHD mortality in subclinical hypothyroidism were similar among individuals with and without TPOAbs [hazard ratio (HR) 1.15, 95% confidence interval (CI) 0.87-1.53 vs HR 1.26, CI 1.01-1.58, P for interaction = .62], as were risks of CHD events (HR 1.16, CI 0.87-1.56 vs HR 1.26, CI 1.02-1.56, P for interaction = .65). Risks of CHD mortality and events increased with higher thyrotropin, but within each stratum, risks did not differ by TPOAb status. Conclusions: CHD risk associated with subclinical hypothyroidism did not differ by TPOAb status, suggesting that biomarkers of thyroid autoimmunity do not add independent prognostic information for CHD outcomes.

References Powered by Scopus

Measuring inconsistency in meta-analyses

48594Citations
N/AReaders
Get full text

Bias in meta-analysis detected by a simple, graphical test

42585Citations
N/AReaders
Get full text

Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)

25648Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Global epidemiology of hyperthyroidism and hypothyroidism

926Citations
N/AReaders
Get full text

Hypothyroidism

771Citations
N/AReaders
Get full text

Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline

660Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Collet, T. H., Bauer, D. C., Cappola, A. R., Åsvold, B. O., Weiler, S., Vittinghoff, E., … Rodondi, N. (2014). Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: An individual participant data analysis. Journal of Clinical Endocrinology and Metabolism, 99(9), 3353–3362. https://doi.org/10.1210/jc.2014-1250

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

53%

Researcher 10

29%

Professor / Associate Prof. 5

15%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 27

75%

Social Sciences 5

14%

Nursing and Health Professions 2

6%

Arts and Humanities 2

6%

Save time finding and organizing research with Mendeley

Sign up for free